Managing fibromyalgia
Fibromyalgia, now recognized as a true health syndrome with origins in the central nervous system, has seen many recent evolutions regarding its diagnosis and management which should instil… read more.
Fibromyalgia, now recognized as a true health syndrome with origins in the central nervous system, has seen many recent evolutions regarding its diagnosis and management which should instil… read more.
Dietary nicotine may hold protective key. New research reveals that Solanaceae—a flowering plant family with some species producing foods that are edible sources of nicotine—may provide a protective… read more.
FDA Highlights by Bruce Sylvester – Patients suffering chemotherapy-induced peripheral neuropathy treated with the anti-depressant duloxetine for 5 weeks achieved a greater reduction in pain compared with patients… read more.
World Health Matters (Japan) by Gary Finnegan – Addiction may result from abnormal brain circuitry in the frontal cortex, the part of the brain that controls decision-making, according… read more.
Major journal reports study findings. A study in the JAMA Neurology suggests that controlling or preventing risk factors such as hypertension earlier in life may limit or delay the brain… read more.
Research illuminates a molecular mechanism for why a stimulating environment may protect against Alzheimer’s Disease.
The first large, population-based study to follow children with attention-deficit hyperactivity disorder (ADHD) into adulthood shows that ADHD often doesn’t “go away,” and that children with ADHD are… read more.
World Health Matters – France – by Gary Finnegan – The detrimental effects of obesity are well-documented with public health specialists warning of a tidal wave of diabetes… read more.
World Health Matters – China – by Gary Finnegan – A study of nearly 6,000 people in five provinces in China has shown that people exposed to passive… read more.
FDA Highlights by Bruce Sylvester – According to a study published online on Nov. 20, 2012 in Arthritis and Rheumatism, rituximab appears to benefit patients with antiphospholipid antibodies… read more.
FDA Highlights by Bruce Sylvester – Women who start hormone therapy within 5 years of menopause onset could reduce their risk of developing Alzheimer’s disease,
FDA Highlights by Bruce Sylvester – Women who start hormone therapy within 5 years of menopause onset could reduce their risk of developing Alzheimer’s disease,
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.